-
Evaluating the Validity of Immunotherapy in Retreatment and Rechallenge Strategies for Oncology Patients
Sep 9, 2025, 16:22 PM -
Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal
Sep 9, 2025, 16:22 PM -
Real-World Adherence to Nonhormonal Therapies for Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Assessment of the Inclusion and Importance of Carer Quality of Life in Global Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Sep 9, 2025, 16:22 PM -
Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
A Systematic Review and Network Meta Analysis of Pharmacologic Disease-Modifying Therapies for Early Alzheimer's Disease
Sep 9, 2025, 16:22 PM -
Leveraging Large Language Models and EMR Data to Identify Undiagnosed Rare Diseases: A Hybrid AI Approach
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Spain: A Scoping Review
Sep 9, 2025, 16:22 PM -
Assessing the Potential Impact of NICE’s Updated HST Routing Criteria on Ultraorphan Drugs
Sep 9, 2025, 16:22 PM -
Mind the Gap: Exploring Variation in Guidelines for Indirect Treatment Comparison (ITC) Across Europe
Sep 9, 2025, 16:22 PM -
From Methods to Decisions: A Transparent Framework for Population-Adjusted Treatment Comparisons
Sep 9, 2025, 16:22 PM -
Statistical Analysis of Health Technology Assessment Outcomes in Oncology: An Analysis of Key Clinical Value Drivers in Germany and France
Sep 9, 2025, 16:22 PM -
Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study
Sep 9, 2025, 16:22 PM -
Disease Severity at Advanced Therapy Initiation in Real-World Psoriasis Patients in the US
Sep 9, 2025, 16:22 PM -
The Impact of Generalized Anxiety Disorder on Comorbid Conditions: A Systematic Review
Sep 9, 2025, 16:22 PM -
Small Molecules vs. Biologics Patterns of Indication Expansion and the Potential Impact of Medicare Price Negotiation
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea
Sep 9, 2025, 16:22 PM -
Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products
Sep 9, 2025, 16:22 PM
